Skip to content

Improving Dynamic Balance and Gait Adaptability Using Treadmill Training

Improving Dynamic Balance and Gait Adaptability Using Treadmill Training With Visual Cues in Subjects With Neurological Disorders: Design of a Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03201692
Enrollment
48
Registered
2017-06-28
Start date
2017-07-01
Completion date
2019-04-10
Last updated
2017-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Parkinson Disease, Stroke

Brief summary

Balance and gait problems in subjects with neurological disease lead to reduced mobility, loss of independence and frequent falls. Treadmill training is a widely used form of treatment and it has been used in subjects with neurological disease to ameliorate walking and balance deficits. The Virtual Reality Treadmill as a therapeutic tool has been recently introduced to practice gait adaptability elicited by aligning foot placement relative to the projected visual context. Forty-eight subjects with neurological disease will receive treadmill training treatment randomly divided in Traditional Treadmill training and Virtual Reality Treadmill training. The aim of this randomized controlled study is to assess whether Treadmill training with Virtual Reality is better than Traditional Treadmill training in improving dynamic balance and cognitive aspects in subjects with neurological diseases.

Interventions

Subjects in the experimental group will receive 40 minutes comprising exercises focused on improving dynamic balance following auditory and visual cues.

DEVICETreadmill training

Subjects in the active comparator group will receive 40 minutes walking training aimed to improve velocity and endurance.

Sponsors

Fondazione Don Carlo Gnocchi Onlus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Multiple Sclerosis (no relapse within the previous three months;), Parkinsons Disease (Hoenhn and Yahr Scale ≤4), Stroke (Time from onset \>2 months) * Able to walk 20 meters with or without assistive device * Cognitive impairment (MMSE score ≥ 21)

Exclusion criteria

* Unable to understand the aim of the study and unable to sign the informed consent * Steroidal drugs therapy for subjects with Multiple Sclerosis * Subjects with Psychiatric disorders * Subjects with Visual impairments * Subjects with cardiovascular disease

Design outcomes

Primary

MeasureTime frameDescription
Change in the Modified Dynamic Gait IndexChange from Baseline Modified Dynamic Gait Index scores at 3-5 weeksTool used to assess dynamic balance
Change in the 6 minutes walking testChange from Baseline 6 minutes walking test scores at 3-5 weekstool used to assess walking endurance

Secondary

MeasureTime frameDescription
Change in Activity Balance ConfidenceChange from Baseline Activity Balance Confidence scores at 3-5 weeksTool used to assess of balance confidence in daily life activities
Change in 10-meter walking testChange from Baseline10-meter walking test scores at 3-5 weeksTool used to assess walking speed in 3 different conditions ( normal speed, fastest speed, cognitive dual task)
Change in Trial Making testChange from Baseline Trial Making test scores at 3-5 weeksThe Trail Making Test is a neuropsychological tapping visual attention and task switching. The test can provide information about visual search speed, scanning, speed of processing, mental flexibility, as well as executive functioning.
Change in Raven's MatricesChange from Baseline Raven's Matrices scores at 3-5 weeksTest used in measuring abstract reasoning and regarded as a non-verbal estimate of fluid intelligence.

Countries

Italy

Contacts

Primary ContactPaolo MOcarelli, MD
pmocarelli@dongnocchi.it+390210308
Backup ContactDavide Cattaneo, PhD
dcattaneo@dongnocchi.it+390240308

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026